CoronaryEfficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic Substudy
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
The ABSORB EXTEND, ABSORB II, ABSORB III, and ABSORB Japan trials have been sponsored and funded by Abbott Vascular. Dr. Kereiakes has received research funding from Abbott Vascular and Boston Scientific; and has served as a consultant for Abbott Vascular, Boston Scientific, Svelte Medical Systems, Micell Technologies, and Sino Medical Sciences Technology. Drs. Ellis and Chevalier have served as consultants for Abbott Vascular. Dr. Kimura has served on the advisory board of and received research grant support from Abbott Vascular. Dr. Abizaid has received research grant support from Abbott Vascular. Dr. Zhao, Susan Veldhof, Minh-Thien Vu, and Dr. Zhang are full time employees of Abbott Vascular. Dr. Onuma has served on the advisory board of Abbott Vascular. Dr. Stone has served as consultant for Reva Corp. Dr. Serruys has reported that he has no relationships relevant to the contents of this paper to disclose.